Repeated peripheral nerve blocks by the co-administration of ketamine, morphine, and bupivacaine attenuate trigeminal neuralgia
To the Editor: Trigeminal neuralgia, an extreme form of neuropathic pain, continues to be a challenge in clinical pain management. In general, neuropathic pains involve multiple factors and conventional methods of pain relief are not always successful. Surgical treatment and neurolytic blocks have side effects. Here, we describe therapy by multiple peripheral nerve blocks with coadministration of bupivacaine, ketamine, and morphine for trigeminal neuralgia relief.
Three patients with chronic severe trigeminal neuralgia who experienced failure of pain relief by conventional analgesics, were treated by multiple peripheral nerve blocks with the co-administration of ketamine (10 mg), morphine (1 mg) in 2 mL of bupivacaine (K+M+B) which resulted in dramatic pain relief. Before treatment, their pain scores were approximately 8 on a scale of 10 and light touch on the cheek resulted in allodynia with an evoked-pain intensity of 9 out of 10. After multiple trigeminal nerves blocks with K+M+B, the pain intensity was reduced gradually to a score of 2-3/10. After the series of blocks, the patients' pain was well controlled with conventional oral analgesics at three months follow-up, and no sensory or motor disturbances were found with the nerve blocks.
Woolf and Thompson have shown that N-methyl-Daspartate (NMDA) receptor antagonists prevent the induction of central sensitization and abolish the postinjury pain hypersensitivity state. 1 Chapman and Dickenson also showed that co-administration of a low dose of morphine and a submaximal dose of 7chlorokynurenate (an antagonist at the glycine site of the NMDA receptor) have a synergic effect in abolishing the noxious input and 'wind-up' of the spinal cord dorsal horn neurons in rats. 2 These observations suggest that there is an interaction between opioid and NMDA receptors in the processing of nociception. In addition, Tverskoy et al. also showed that ketamine enhances the peripheral anesthetic and analgesic effects of bupivacaine via a peripheral mechanism. 3 Moreover, opioid receptors have been identified on peripheral nerve terminals of primary afferent fibres. A synergistic effect was also seen between the local anesthetic, bupivacaine, and morphine for peripheral analgesia. 4 Furthermore, in previous clinical reports, we have shown that this analgesic regimen (K+M+B) provides satisfactory pain relief for other neuropathic pain syndromes. 5 These findings support the present report that ketamine, morphine and bupivacaine also provide pharmacological synergy, via a peripheral mechanism, in the treatment of trigeminal neuralgia. The regimen appears to be beneficial for the treatment of trigeminal neuralgia. 
Evaluation of the Arrow Flex Tip Plus™ epidural catheter tip position and migration during continuous thoracic analgesia
To the Editor: Catheter tip position influences the effectiveness of epidural anesthesia. 1 The Flex Tip Plus™ (Arrow International Inc., Reading, USA) is extremely flexible and this may influence catheter tip position and migration. However the position of this catheter in the thoracic epidural space remains unclear. After obtaining Institutional approval and informed consent, 60 patients undergoing lung surgery were studied. The catheter tip position on postoperative days one and two was compared with that just after surgery (day zero) using chest radiography. Most epidural catheters were inserted at T 3-4 or T 4-5 , ranging from T 1-2 to T 6-7 and 95% were inserted by a paramedian approach. The catheter was threaded 3-5 cm into the epidural space. In 70% of patients (42/60) the catheter tips were visualized. On day zero, the catheter tips were located within one vertebral body from the inserted interspace in 64% of patients (Table) . Patients whose catheter tip was located within one vertebra from the insertion point were significantly older (62 ± 15 yr) than those whose catheter tip was located beyond two vertebrae (48 ± 21 yr). In ten patients, the catheter tip moved more than one vertebra during the study period. In nine of these ten patients, the catheter tip at day zero was located more than two vertebrae cephalad from the insertion point and moved caudally. Those patients in whom the catheter stayed within one vertebra were significantly older than those in whom the catheter moved (60 ± 16 vs 46 ± 21, P < 0.05). Catheter tip remained within the epidural space in all patients.
In young patients, the epidural space is packed tightly with rigid fat 2 and is poorly compliant. 3 It is speculated that an epidural catheter advances smoothly in elderly patients but our results contradict this hypothesis. This may be because this specific catheter is so soft that it changes direction easily when it runs against an obstacle.
Although the orifice of the epidural needle was directed cephalad and the catheter was advanced 3-5 cm, only 36% of catheter tips were positioned more than two vertebrae cephalad. Lumbar epidural catheters follow a cephalad direction in 70% of cases. 4 Another study using the same catheter as in this study, showed a cephalad position in only 39% of patients. 5 The Flex Tip Plus™ is made of a very soft polyurethane polymer which may cause the catheter to curl up in the epidural space.
In conclusion, the tip of the Flex Tip Plus™ catheter tends to stay at the level of insertion when inserted in the thoracic epidural space, especially in elderly patients. 
Movement of the catheter tip
Catheter tip moved more than one 10 (24) 46 (21) vertebra during study period Catheter tip stayed within one 32 (76) 60 (16)* vertebra during study period * Indicates a statistically significant difference between groups (P < 0.05).
